Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 0.2854 USD -87.65% Market Closed
Market Cap: 45.4m USD

Intrinsic Value

MREO latest financial reports are more than 2 years old.

The intrinsic value of one MREO stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.2854 USD, Mereo Biopharma Group PLC is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

MREO Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case
Compare MREO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MREO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mereo Biopharma Group PLC

Current Assets 52.4m
Cash & Short-Term Investments 48.7m
Receivables 2.8m
Other Current Assets 913k
Non-Current Assets 1.2m
PP&E 552k
Intangibles 643k
Current Liabilities 6m
Accounts Payable 879k
Accrued Liabilities 4.2m
Other Current Liabilities 902k
Non-Current Liabilities 988k
Other Non-Current Liabilities 988k
Efficiency

Free Cash Flow Analysis
Mereo Biopharma Group PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mereo Biopharma Group PLC

Revenue
500k GBP
Cost of Revenue
-132k GBP
Gross Profit
368k GBP
Operating Expenses
-47.2m GBP
Operating Income
-46.8m GBP
Other Expenses
5.1m GBP
Net Income
-41.7m GBP
Fundamental Scores

MREO Profitability Score
Profitability Due Diligence

Mereo Biopharma Group PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
hidden
Profitability
Score

Mereo Biopharma Group PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

MREO Solvency Score
Solvency Due Diligence

Mereo Biopharma Group PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Mereo Biopharma Group PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MREO Price Targets Summary
Mereo Biopharma Group PLC

Wall Street analysts forecast MREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MREO is 7.14 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

Lowest
Price Target
5.05 USD
1 669% Upside
Average
Price Target
7.14 USD
2 402% Upside
Highest
Price Target
9.45 USD
3 211% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Mereo Biopharma Group PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for MREO is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MREO Insider Trading
Buy and sell transactions by insiders